General Atlantic Genpar (bermuda), L.P., 10% Owner at CinCor Pharma, Inc. (CINC), bought 83,000 shares at $30.00 ($2.5M) on 2022-08-11, disclosed to the SEC on 2022-08-15.
Open-market purchase of $2.5M CINC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| ALKT | BUY | 2026-03-16 | $9.2M | — | Filing → |
| ALKT | BUY | 2026-03-11 | $50.6M | — | Filing → |
| ALKT | SELL | 2024-11-27 | $119.3M | — | Filing → |